Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 we » 1_ we (Expand Search), 10 re (Expand Search), 16 we (Expand Search)
Showing 1 - 20 results of 91 for search '(((( 59 ((a decrease) OR (mean decrease)) ) OR ( 10 we decrease ))) OR ( 50 we decrease ))~', query time: 2.28s Refine Results
  1. 1
    Flowchart of patients.

    Flowchart of patients. by Seydou Goro (17847203)

    Published 2024
    Save to List
    Saved in:
  2. 2
    Flowchart of population spatialization.

    Flowchart of population spatialization. by Zhen Zhao (159931)

    Published 2025
    Save to List
    Saved in:
  3. 3
    The effect of MSC blocker GsMTx-4 on photoresponses from <i>Xenopus</i> rods.

    The effect of MSC blocker GsMTx-4 on photoresponses from <i>Xenopus</i> rods. by Ulisse Bocchero (9128127)

    Published 2020
    Save to List
    Saved in:
  4. 4
    Supplementary materials.

    Supplementary materials. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  5. 5
    Summary of subgroup analysis results.

    Summary of subgroup analysis results. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  6. 6
    PRISMA Flow Chart 2020.

    PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  7. 7
    Included and excluded studies.

    Included and excluded studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  8. 8
    Characteristics of included studies.

    Characteristics of included studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  9. 9
    Extraction data table.

    Extraction data table. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
    Save to List
    Saved in:
  10. 10
    DataSheet_1_Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins.pdf

    DataSheet_1_Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins.pdf by Rikke Hjortebjerg (16010939)

    Published 2023
    Save to List
    Saved in:
  11. 11
    Influence of pre-treatment blood pressure levels on antihypertensive drug benefits in diabetics: the roadmap experience

    Influence of pre-treatment blood pressure levels on antihypertensive drug benefits in diabetics: the roadmap experience by Christos Chatzikyrkou (2792542)

    Published 2020
    Save to List
    Saved in:
  12. 12
    Image_6_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_6_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  13. 13
    Image_3_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_3_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  14. 14
    Image_8_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_8_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  15. 15
    Image_7_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_7_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  16. 16
    Image_4_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_4_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  17. 17
    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  18. 18
    Image_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  19. 19
    DataSheet_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.docx

    DataSheet_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.docx by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:
  20. 20
    Image_2_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_2_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. …”
    Save to List
    Saved in:

Search Tools: